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Neural tube defects and elevated homocysteine levels in 
amniotic fluid
Régine P. Steegers-Theunissen, MD,“1 h Godfried H, Boers, MD,C Henk J. Blom, PhD, 
Jan G. Nijhuis, MD," Chris M.G. Thomas, PhD,“ George F. Borm, PhDsc and 
Tom K. Eskes, MD”
Nijmegen, The Netherlands
OBJECTIVE: Our purpose was to study maternal blood and amniotic fluid concentrations of 
homocysteine and relevant vitamins in relation to neural tube defects,
STUDY DESIGN; Concentrations of total homocysteine, folate, and vitamins B12 and Be were measured 
in maternal blood and amniotic fluid of 27 women carrying a fetus with a neural tube defect and 31 
control women carrying a healthy fetus,
RESULTS: The mean total homocysteine concentration in amniotic fluid of the study group was 
significantly higher than that of the control group. The mean concentrations of total homocysteine In 
blood and the vitamins folate, B12, and Be in, respectively, blood and amniotic fluid were not significantly 
different between the groups. The mean concentrations of homocysteine and vitamin B6 were significantly 
lower in amniotic fluid than in blood in both groups, whereas vitamin B12 in amniotic fluid was higher than 
in blood.
CONCLUSION: These results support the hypothesis that at least the cause of a subset of neural tube 
defects could reside in a primary or secondary maternal or fetal derangement of homocysteine 
metabolism. (Am J O bste t G yneco l 1995;172:1436-41.)
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Decreased levels o f folate and  vitam in B.,, in m ater- 
nal blood have been  associated with the pathogenesis of 
neural tube defects.1, a Periconceptional folate trea t­
m ent of the m o th e r is very likely to prevent neural tube 
defects/* 5 Recently we repo rted  an association between 
a history o f  offspring with a neural tube defect and  
m aternal mild hyperhom ocysteinem ia in the  lasting 
state and after m eth ion ine  loading.5, B However, it is 
unclear what biochemical m echanism  is involved, but 
probably the underly ing  defect is located in the re- 
methylation pathway o f homocysteine m etabolism .
5-M ethyltetrahydrofolate and B ]L, as methylcobal- 
am in are involved in the  rem ethylation of hom ocysteine 
to methionine. Vitamin B0 as pyridoxal phosphate  is 
involved in the com peting  transsulfuration pathway, 
which degrades hom ocysteine by cystathionine into cys­
teine. M alnutrition o r  a de ran g ed  metabolism  of folate 
or vitamin B 12 im pairs the rem ethylation to m eth ionine 
and results in hyperhom ocysteinem ia.7'9 T he m ost fre-
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quently encoun tered  inherited  enzymatic defects in ho­
mocysteine m etabolism  are deficiencies of the enzymes 
cystathionine synthase and  5,10-methylenetetrahydro- 
folate reductase .” Noteworthy is the recently reported 
decreased enzyme activity o f  a thermolabile form of 
5,10-m ethylenetetrahydvofolate reductase, which may 
result in mild hyperhom ocysteinem ia in 5% of the 
general p o p u la tio n .10 Increased homocysteine blood 
levels can be efficiently lowered by high-dose folate or 
vitamin B(i.u *
In view o f the previously reported association of 
m aternal hyperhom ocysteinem ia and offspring with a 
neural tube defect;, it would be intriguing to study the 
homocysteine exposure  o f  the conceptus during the 
period that neural tube defects develop (i.e., third to 
fourth week after conception). However, it is not fea­
sible to assess the hom ocysteine concentrations in the 
yolk sac, in  the  neural tissue, or even in amniotic fluid 
during tha t early stage of h u m an  pregnancy. Therefore 
we studied both  m aternal blood and mid trim ester am ­
niotic fluid concentrations o f  total homocysteine, folate, 
and vitamins B la and Br> in women carrying a fetus with 
a neural tube defect and  in a control group o f  women 
carrying a norm al, healthy fetus.
Material and methods
Fifty-eight women were investigated after written in­
formed consent; was obtained. Exclusion criteria were 
gastrointestinal and endocrine  disorders, dietary re-
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Table I. Characteristics o f  popula tions
Group 1 (N TD )  
(n =  27)
Group 2  (controls)
(n -  31) Significance
Age (yr) (m ean  a n d  SD) 30.5 (4.2) 37.8 (1.3) p  < 0.01
Nulli parous 9 7 NS
Gestational age (wk) (m ean  an d  SD)* 22.3 (8.8) 15.9 (0.7) p  <  0.01
NTD, Neural tube defect; NS, no t significant 
*At amniocentesis,
Table II, Mean and SD am nio tic fluid and m aternal blood concentrations o f  total homocysteine and 
vitamins in wom en carrying a fetus with a neural tube defect (group 1) and  in women with a healthy 
fetus (group 2)
Group J (N TD )  
(n «  27)
Group 2  (controls) 
(n  «  3 1 ) Significance between groups
Total hom ocysteine (jxmol/L)
Plasma 7.7 (3.2) 7.2 (1.2) NS
Amniotic fluid 2.6 ( 1 .6 ) 1.5 (0,4) p  <  0.01
Significance w ithin g roup p  <  0.01 p  < 0.01
Folate (nmol/L)
Serum 15 (6 ) 15 (6 ) NS
Amniotic fluid 14 (8) 13 (5) NS
Significance w ithin g roup NS p  <  0.01
Red blood cells 646 (324) 644 (170) NS
Vitamin B 1!2 (pmol/L)
Serum 219 (67) 238 (6 6 ) NS
Amniotic fluid 379 (298) 481 (278) NS
Significance w ithin g ro u p p  < 0.05 p <  0 .0 1
Vitamin B(i (nmol/L)
Whole b lood 41 (11) 41 (14) NS
Amniotic fluid 20  (19) 14 (13) NS
Significance w ithin g ro u p p  < 0.01 p  <  0,01
NTD, Neural tube defect; MS’, n o t significant,
strictions, and the use of vitam in p repara tions or o th e r  
pharmacologic agents im m ediately before o r  du ring  the 
current p regnancy . Twonty-s e ve n of the wom en carried 
a fetus with a neural tube defect (i.e., m eningo[m ye- 
cele [n = 15] or auencephaly  [n =  12] (group 1) as 
concluded from a-fe top ro te in  determ inations in am ni- 
otic fluid and from u ltrasonograph ic  exam ination and 
confirmed by the pregnancy  outcom e. T h e  control 
group (group two) consisted of 31 w om en in whom 
amniocentesis was p erfo rm ed  because o f high m aternal 
age (30 to 40 years). All contro l women gave b irth  to a 
healthy child. All p regnancies  were accurately da ted  by 
the last m enstrual p e rio d  and  by first-trim ester ultraso­
nographic investigation. T h e  characteristics o f both 
groups are p resen ted  in T ab le  I.
Venous blood sam ples for the dete rm ination  of 
plasma total hom ocysteine, serutn  and  red  blood cell 
folate, serum vitam in B ^ , and whole blood vitamin Bn 
as pyridoxal p h o sp h a te  were taken within 10 m inutes 
after amniocentesis. Amniotic fluid sam ples were ob­
tained by rou tine  transabdom inal am niocentesis and 
collected in dry tubes o f  10 ml. All amniotic fluid 
samples were free from  blood contam ination. T h e  
samples were im m ediately  centrifuged for 10 m inutes at. 
3000 g, stored a t - 2 0 °  C, and assayed wit 1 iin 3 m onths
after collection. T h e  analytic m ethods used in the d e­
term ination  of vitamins in blood and amniotic fluid 
have been  rep o rted  b e fo re .1,4 Total homocysteine was 
de te rm ined  essentially according to Fiskerstrand et a l.H
Results are  expressed as m ean (SD), To obtain n o r­
mality, blood and am nion param eters were log-trans­
form ed. Possible differences between the groups were 
then  evaluated with Welch’s I test, whereas differences 
betw een paired  observations were validated with the 
S tuden t / test. Pearson’s partial correlation coellicients 
(with the g roup  effect partialed  out) were calculated to 
study the relationship between the various variables. A 
p value < 0.05 was considered statistically significant.
Results
Amniocentesis was perfo rm ed  at a significantly more 
advanced gestational age in group 1 com pared with 
g ro u p  2, and  the wom en in group  2 were significantly 
o lder than  those in g roup  1 (Table I).
T h e  m ean concentrations of total homocysteine, 
folate, and  vitamins and  B(i in m aternal blood and 
am niotic fluid as found  in groups I and 2 are given in 
T able  II. T h e  m ean amniotic fluid concentration of 
total hom ocysteine in g roup  1 was significantly higher 
than  that o f g roup  2 (p < 0.01), whereas these concen-
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Fig. 1. Individual plasm a and am nio Lie fluid levels of homocysteine in women carrying a fetus with 
a neura l tube delec t (NTD) (group 1) and  in those carrying a healthy fetus (group 2). Horizontal nde, 
M ean.
Table III. Partial correlation coefficients of concentrations of total homocysteine in both plasma 
and amniotic fluid with concentrations of folate, vitamin Bi;a, vitamin Br>, and gestational and 
maternal age
Total homocysteine
Plasma Significance Amniotic fluid Significance
M aternal ajje - 0 .0 7 NS - 0 .0 4 NS
\  . w
Gestational age - 0 .3 5 p  < 0.05 - 0 .0 5 NS
T o  t a 1 ho in o cy s t e i n e
Plasma — 0.45 p <  0.01
Folate
Serum -  0.40 p  < 0.01 -  0 .3 6 p <  0.01
Red blood cells -  0,55 p  < 0.01 “ 0.30 p <  0.05
Amniotic fluid -  0.19 NS -  0.43 p < 0.01
Vitamin B la
Serum — 0.21 NS -0.1(5 NS
Amniotic fluid “  0.84 p  < 0.05 - 0 .2 3 NS
Vitamin Bn
Whole b lood 0,16 NS - 0.002 NS
Amniotic fluid 0.06 NS - 0 .0 6 NS
MS’, Not significant;.
trations in plasm a did n o t  d iffer  significantly. T w elve  o f  
27 cases o f  the study g ro u p  dem onstrated  total h o ­
m ocystein e co n cen tratio n s in am niotic fluid exceed in g  
the m ean  plus twice th e  SD  o f  the control gro u p  (i.e., 
> 2.3 fxmol/L). T h e  in d iv id u a l total hom ocysteine con­
centrations in am n io tic  fluid an d  plasm a in both groups 
are show n in Fig, 1.
T h e  m ean am n io tic  flu id  concentrations o f  folate and 
vitam ins B12 an d B(J d id  n o t significantly differ between 
the two groups ('Fable II). Similarly, none o f the vita­
mins d eterm in ed  in b lo o d  w ere  significantly different 
betw een the two g ro u p s.
In both gro u p s the m e a n  total plasm a hom ocysteine
and whole b lood vitamin B 0 concentrations w ere signifi­
cantly h igher than those o f  the co rresp o n d in g  am niotic 
fluid samples. O nly in gro u p  2 was a significantly lower 
m ean am niotic fluid fo late  concen tration  found co m ­
pared with the m ean serum  folate  value. In groups 1 
and 2 the m ean vitam in levels o f  am niotic  fluid 
were significantly h igher than those in serum . T h e r e  
was no significant d ifference in the m ean vitam in B 0 
concentration in w hole b lood o r  am niotic fluid between 
groups 1 and 2 , T h e  m ean vitam in B 0 concentrations in 
am niotic fluid an d m aternal b lood  did differ signifi­
cantly within the groups.
Pearson’s partial coefficients o f  correlation w ere cal-
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Fig. 2. Correlations o f  concentrations o f total hom ocysteine in am niotic  fluid with gestational age 
and vitamin B 12 in amniotic fluid and  with folate in am niotic fluid an d  serum . NTD, Neural tube
culated between total homocysteine, the various vitamin 
levels, and m aternal and gestational age. Because the 
correlations appeared  not to be significantly di fie ren t 
between the groups and  regression lines were parallel, 
congelation coefficients were calculated for both groups 
combined. T he correlations are shown in Table III and 
Fig. 2. T he total homocysteine concentrations in 
plasma and amniotic fluid were not significantly co rre­
lated with maternal age. Only plasma, not amniotic 
fluid total homocysteine concentrations, showed a sig­
nificant inverse correlation with gestational age, Folate 
levels in maternal serum  and red blood cells were 
significantly inversely correlated with total homocys­
teine in amniotic fluid. Also, vitamin B lt, in amniotic 
fluid and maternal plasma homocysteine levels did  
show a significant inverse correlation.
Comment
This study dem onstrates that p regnant women carry­
ing a fetus with a neural tube defect (group 1) have 
significantly higher total homocysteine levels in am ni­
otic fluid than do controls (group 2). However, plasma 
total homocysteine levels did not differ significantly 
between groups, Plasma levels o f either group were 
lower than those of* nonp regnan t women (7.2 |imol/L in 
pregnant control women vs 0.8 (xmol/L in non p regnan t 
women'1), which is in accordance with other studics.,‘r,, 1,1 
This finding might be related to hcmodilution, in ­
creased remethylation o f  homocysteine induced by e n ­
hanced  d em ands for m ethionine by the fetus or to the
4
im pact o f  increased sex horm one levels during p reg ­
nancy on hom ocysteine m etabolism .17, ,H
T h e  total hom ocysteine concentrations in amniotic 
fluid of both g roups were significantly lower in amniotic 
fluid than in plasma, as has been demonstrated previ­
ously in norm al p reg n an c ies .1* In the current study a 
significant positive correlation could be established b e ­
tween the total hom ocysteine concentrations in the two 
com partm ents  (i.e., m aternal plasma and amniotic 
fluid). T h e  transplacental transfer of homocysteine may 
be an important; d e te rm inan t o f  the level of homocys­
teine in am niotic  fluid. T h e  rep o rt of Kurc/ynski et a l.,MI 
who first described an u n trea ted  homoeystimiric p reg ­
nan t woman with dramatically increased homocysteine 
concentration  in am niotic fluid, is in accordance with 
this observation, However, it is not excluded that the 
increased hom ocysteine concentration in amniotic fluid 
is caused by a defective homocysteine metabolism or by 
leakage from tine neural tube defect of the Ictus into the 
am niotic fluid.
'There was no significant; correlation between total 
hom ocysteine in plasm a o r amniotic fluid and gesta­
tional or m ate rn a l age, with the exception of the inverse 
correlation betw een plasm a total homocysteine and  
gestational age. F urtherm ore , it revealed from the study 
o f  A ndersson et al.*0 chat total plasma homocysteine is
directly corre la ted  with age. T herefore  it is very unlikely 
that the significantly h ig h er total homocysteine levels in
1440 Steegers-Theunissen et al. Muy 1995
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amniotic fluid o f  fetuses with a neural tube defect 
compared with healthy controls are a consequence of 
the higher gestational age o r  the lower maternal age at 
which amniocentesis took place for the study group, 
Shojania“1 rep o rted  a progressive decline of serum 
and red blood cell folate and  serum vitamin B ,2 con­
centrations in pregnancy an d  hypothesized that this 
might be caused by increased fetal demands, blood 
volume expansion, and  increased urinary excretion and 
by changes in m aternal folate absorption and m etabo­
lism. In particular, changes in vitamin B 12 binders may 
contribute to the physiologic decrease of this vitamin in 
pregnancy.*1 Decreased blood levels o f  vitamin B(i dur-
I!1
ing pregnancy have also b een  described.*’"
Folate or vitamin B 12 deficiency results in increased 
homocysteine concentrations in blood and urine.8, u A
significantly negative correla tion  between plasma total 
homocysteine and  serum  and red  blood cell folate was 
observed in this study, which is consistent with previous 
studies.0, 11 T he  m ean  folate concentrations in m ater­
nal serum and red  b lood cells and amniotic fluid of 
group 1 were n o t significantly different from those in 
group 2. T herefore  the increased homocysteine levels 
in amniotic fluid o f  g roup  1 cannot solely be explained 
on the basis o f lower folate concentrations.
Also serum vitam in B 12 concentrations were com pa­
rable in the neural tube defect group and control women 
and were revealed to be within the norm al ranges as 
given earlier for w om en of com parable age.IiV ** In  both 
groups vitamin B 12 concentra tions in amniotic fluid were 
significantly h igher than  those in serum. This is in line 
with the results o f previous studies suggesting that there 
is an active transplacental transfer of this vitamin against 
a concentration gradient.
Lower vitamin B 12 levels in amniotic fluid of normal
pregnancies in w om en who previously had an infant 
with a neural lube defect have been determ ined in 
relation to increased am niotic fluid transcobalamin lev­
els."1, This p h en o m e n o n  is thought to be an indica­
tion of a genetic factor in the predisposition of neural 
tube delects. However, in our study the mean vitamin 
B 12 concentration in am niotic fluid was not significantly 
lower in the neural tube defect group compared with 
the control group,
To our knowledge, the presence o f  vitamin B0 in 
human amniotic fluid has not been dem onstrated  be­
fore. In both groups the vitam in B0 levels were signifi­
cantly lower than  in m aternal blood. Its mean concen­
trations in m aternal b lood and  amniotic fluid o f  the 
neural tube defect g roup  were similar to the corre­
sponding values o f  controls. N o significant correlation 
between the concentrations o f  total homocysteine and 
vitamin B(} in blood or am niotic fluid was found.
In conclusion, a significantly h igher mean total ho­
mocysteine concen tra tion  was observed in amniotic
fluid of a pregnancy in which the fetus was affected with 
a neural tube defect compared with a control group. 
This might be the result of a primary or secondary 
derangement in maternal or fetal homocysteine m e­
tabolism, which is in line with our findings and earlier 
findings of others;r,t li' "li
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A new placental enzyme in the metabolism of cocaine: 
An in vitro animal model
Bertis B. Little, MA, PhD, Daniel A, Roe, MD, R. William Stettier, MD,
Van R. Bohman, MD, Kim L, Westfall, MS, and Sohrab Sobhi, BS
Dallas, Texas
OBJECTIVE: The aim of this study was to analyze placental metabolism In a genetically controlled in vitro 
animal model.
STUDY DESIGN: Placentas from Sprague-Dawley rats were centrifuged, and mlcrosomes were Isolated.
Four treatment groups were Incubated with cocaine over four time periods: placental 
mlcrosomes + cocaine, placental mlcrosomes + dllsopropyl fluorophosphate (an 
anticholinesterase) *h cocaine, placental mlcrosomes + cocaine 4* butyryichollnesterase, and a blank 
(cocaine only). Gas chromatography was used to quantify cocaine (Limit of quantitation = 19 ng/ml) and 
metabolites. Gas chromatography/mass spectrometry was used to verify the Identity of the metabolites.
RESULTS: Butyrylchollnesterase enhanced cocaine metabolism to ecgonlne methyl ester. More than 
40% of cocaine was metabolized to norcocalne by rat placenta when dlisopropyl fluorophosphate 
suppressed cocaine. Norcocalne Is produced by hepatic N-demethylase action on methyl-bearing 
nitrogen In cocaine, suggesting that placenta and liver have this capacity. Gas chromatography/mass 
spectrometry was essential to the identification of norcocalne, because norcocalne Is frequently not 
Identified.
CONCLUSIONS: This biotransformation of cocaine to norcocalne may be a primary metabolic pathway 
Induced In the chollnesterase-deflclent placenta. This has clinical Implications because norcocalne Is 
ninefold more active physiologically than cocaine or ecgononlne methylesterase. (Am J O bste t G ynecol 
1995;172:1441-5.)
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